HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today commented on the recent filing by Armistice Capital LLC (“Armistice”), asking the Spectrum Board of Directors to consider certain actions.
Help employers find you! Check out all the jobs and post your resume.
